Peptide record

TPDB45907

Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45907
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 21-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
WNFFDWFSGLMSWFGGPLKLY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C132H168N26O28S1
ARCEQHITV
F
2599.00
6.68
1
1
12
-0
-0.52
0.248
55.71
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
17990
6.92
4
Residue Composition
number
0
A
0
R
1
N
1
D
0
C
0
E
0
Q
3
G
0
H
0
I
3
L
1
K
1
M
4
F
1
P
2
S
0
T
3
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 1 C: 0 E: 0 Q: 0 G: 3 H: 0 I: 0 L: 3 K: 1 M: 1 F: 4 P: 1 S: 2 T: 0 W: 3 Y: 1 V: 0
Chemical Descriptors
21 reviewed residue count
C132H168N26O28S1 sequence-only estimate (linear, free termini)
2599.00 sequence-only estimate (linear, free termini)
6.68 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-0.52 sequence-only estimate (linear, free termini)
0.248 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0